Skip to main content
. 2023 Mar 28;2023(3):CD006127. doi: 10.1002/14651858.CD006127.pub3
Subgroup Studies Participants Risk ratio (M‐H, Random) [95% CI]
Normotensive, type 1 1 (AdDIT) 443 2.99 [0.12, 72.92]
Normotensive, type 2 0 0 Not estimable
Total (95% CI) 1 443 2.99 [0.12, 72.92]